Dr Oliver Bartelsen
As the Head of Business Development at Miltenyi Biotec, Oliver is responsible for the Company’s strategic collaborations with Biotech and Pharma in Cell and Gene Therapy (CGT). Joining Miltenyi Biotec in 2009, he has been instrumental to build the Company’s industry business becoming a global solution provider in the CGT field addressing challenges in development, manufacturing and testing of CGT products. Based on Miltenyi Biotec’s foundations of its tool and reagent catalogue business, Oliver and his team are doing deals with the CGT industry from strategic supply to R&D collaborations in technology platform and CGT product development and contract manufacturing. Before joining Miltenyi Biotec, Oliver worked in the vaccine industry in positions with increasing responsibilities in R&D, project management, industrialization and business development at Rhein Biotech, GreenCross Vaccine, Berna Biotech, Crucell and Dynavax. Oliver holds a doctoral degree in Biochemistry from the University of Bonn, Germany.